Skip to content

Clinical trials

Completed Phase 1 Lymphoma, B-Cell, Marginal Zone trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Phase: Phase 1 Status: Completed Clear all

173 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200010
20017
200213
20037
200412
20054
20068
200712
20086
20097
20106
20115
20124
20132
20144
20152
20163
20175
20184
20191
20204
20213
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed173

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)45
National Institutes of Health Clinical Center (CC)9
Memorial Sloan Kettering Cancer Center8
Case Comprehensive Cancer Center5
Fred Hutchinson Cancer Center5
Mayo Clinic4
Northwestern University4
Regeneron Pharmaceuticals4
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins4
City of Hope Medical Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone173
Lymphoma, Follicular162
Lymphoma, Mantle-Cell160
Leukemia, Lymphocytic, Chronic, B-Cell151
Lymphoma, Large B-Cell, Diffuse140
Lymphoma, Non-Hodgkin136
Burkitt Lymphoma129
Precursor Cell Lymphoblastic Leukemia-Lymphoma123
Lymphoma, Large-Cell, Immunoblastic116
Lymphoma94

Trials

Showing 1 to 25 of 173. Each trial links to its page on Pharma Observatory.

73 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.